Photo: OKSANA KAZYKINA/123RF
Drug maker AFT Pharmaceuticals has reported a strong first-half result with revenue up a third over the year earlier.
The company best known for its Maxigesic pain medication made a first net half profit compared with a loss the year earlier, with the businesses Australian divison being its
Continue Reading on RNZ
This preview shows approximately 15% of the article. Read the full story on the publisher's website to support quality journalism.